US2008187926A1PendingUtilityA1

Detection of Small Nucleic Acids

Assignee: THIRD WAVE TECH INCPriority: Dec 18, 2002Filed: Oct 30, 2007Published: Aug 7, 2008
Est. expiryDec 18, 2022(expired)· nominal 20-yr term from priority
C12Q 1/6816Y10T436/145555
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to compositions and methods for the detection and characterization of interfering RNAs such as micro RNAs (miRNAs) and small interfering RNAs (siRNAs) and other short nucleic acid molecules. More particularly, the present invention relates to improved methods for the detection and quantitation of interfering RNA expression. The present invention further provides for the detection of variants and types of miRNAs and siRNAs.

Claims

exact text as granted — not AI-modified
1 . A method, comprising:
 a) hybridizing an interfering RNA target to at least one nucleic acid that contains sequence not complementary to said interfering RNA target to generate a detection structure; and   b) detecting said detection structure.   
     
     
         2 . The method of  claim 1 , wherein said interfering RNA target is an miRNA. 
     
     
         3 . The method of  claim 1 , wherein said interfering RNA target is an siRNA. 
     
     
         4 . The method of  claim 3 , wherein said siRNA is double stranded. 
     
     
         5 . The method of  claim 1 , wherein said detection structure comprises an invasive cleavage structure. 
     
     
         6 . The method of  claim 2 , wherein said detection structure comprises first and second oligonucleotides configured to form an invasive cleavage structure in combination with said miRNA. 
     
     
         7 . The method of  claim 2 , wherein said detection structure comprises a first oligonucleotide configured to form an invasive cleavage structure in combination with said miRNA. 
     
     
         8 . The method of  claim 6 , wherein said first oligonucleotide comprises a 5′ portion and a 3′ portion, wherein said 3′ portion is configured to hybridize to said target sequence, and wherein said 5′ portion is configured to not hybridize to said target sequence. 
     
     
         9 . The method of  claim 6 , wherein said second oligonucleotide comprises a 5′ portion and a 3′ portion, wherein said 5′ portion is configured to hybridize to said target sequence, and wherein said 3′ portion is configured to not hybridize to said target sequence. 
     
     
         10 . The method of  claim 1 , wherein said detecting comprises use of an invasive cleavage assay. 
     
     
         11 . The method of  claim 1 , wherein said detection structure comprises a circular oligonucleotide hybridized to said miRNA to generate a circular detection structure. 
     
     
         12 . The method of  claim 11 , wherein said detecting comprises use of a rolling circle replication assay. 
     
     
         13 . The method of  claim 1 , wherein said detecting comprises use of a detection assay selected from the group consisting of sequencing assays, polymerase chain reaction assays, hybridization assays, hybridization assays employing a probe complementary to a mutation, microarray assays, bead array assays, primer extension assays, enzyme mismatch cleavage assays, branched hybridization assays, NASBA assays, molecular beacon assays, cycling probe assays, ligase chain reaction assays, invasive cleavage structure assays, ARMS assays, and sandwich hybridization assays. 
     
     
         14 . The method of  claim 1 , wherein said detecting is carried out in cell lysates. 
     
     
         15 . The method of  claim 1 , wherein a plurality of different miRNAs are detected. 
     
     
         16 . The method of  claim 15 , wherein said plurality of miRNAs comprise a first miRNA and a second miRNA that is said first miRNA having a polymorphism. 
     
     
         17 . The method of  claim 1 , further comprising detecting a second nucleic acid target. 
     
     
         18 . The method of  claim 17 , wherein said second nucleic acid target is RNA. 
     
     
         19 . The method of  claim 18 , wherein said second nucleic acid target is selected from the group consisting of U6 and GAPDH. 
     
     
         20 . The method of  claim 2 , wherein said miRNA is selected from the group consisting of Let-7, miR-1, miR-135, miR-15, miR-16, miR125b, miR-1d, and miR124a. 
     
     
         21 . A kit comprising a nucleic acid configured for forming a detection structure when hybridized to an interfering RNA target sequence, wherein the nucleic acid comprises sequence that is not complementary to said interfering RNA target sequence. 
     
     
         22 . The kit of  claim 21 , wherein said detection structure comprises an invasive cleavage structure. 
     
     
         23 . The kit of  claim 22 , wherein said first oligonucleotide comprises a 5′ portion and a 3′ portion, wherein said 3′ portion is configured to hybridize to said target sequence, and wherein said 5′ portion is configured to not hybridize to said target sequence. 
     
     
         24 . The kit of  claim 22 , wherein said second oligonucleotide comprises a 5′ portion and a 3′ portion, wherein said 5′ portion is configured to hybridize to said target sequence, and wherein said 3′ portion is configured to not hybridize to said target sequence. 
     
     
         25 . The kit of  claim 21 , wherein said detection structure comprises a circular oligonucleotide hybridized to said miRNA to generate a circular detection structure. 
     
     
         26 . The kit of  claim 25 , wherein said detection structure is a detection structure for a rolling circle replication assay. 
     
     
         27 . The kit of  claim 21 , wherein said interfering RNA target is an miRNA. 
     
     
         28 . The kit of  claim 21 , wherein said interfering RNA target is an siRNA. 
     
     
         29 . The kit of  claim 27 , wherein said miRNAs are selected from the group consisting of Let-7, miR-1, miR-135, miR-15, miR-16, miR-1b, miR-124a, and miR125b. 
     
     
         30 . The kit of  claim 21 , wherein the kit is configured to detect an miRNA target and at least one other RNA target. 
     
     
         31 . The kit of  claim 21 , wherein the kit is configured to detect said interfering RNA target sequence in a cell lysate.

Join the waitlist — get patent alerts

Track US2008187926A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.